Monthly Archives: February, 2024

Novo Holdings Hones in on Catalent

As pharmaceutical companies race to find the next generation of medicines, Novo Holdings announced it will acquire Catalent, Inc. The all-cash deal values Catalent...

Temu: Sue like a Billionaire?

As narratives like musician Taylor Swift's relationship with Kansas City tight end Travis Kelce enraptured the nation during this year's Super Bowl, one company...

The Corporate Transparency Act: A New Attempt to Fight Money Laundering with Lori Smith

Laundering money generated in the drug trade. The United Nations Office on Drugs and Crime estimates that between $800 billion to $2 trillion is...

Hunch Goes Public as India Takes Flight

Eager to tap India’s rapidly growing luxury market, Hunch Mobility announced it will be going public via a SPAC acquisition. The company, officially named...

Roasted: The Lawsuits Faced by America’s Biggest Coffee Chain

In a November 2023 press release, ubiquitous coffee chain Starbucks unveiled its plan for a "limitless future" - the "Triple Shot Reinvention with two...

“Litigators, YES Litigators: One Attorney’s Journey Within and Without the Legal Industry” with Somya Kaushik

Litigators who do other things besides litigate -- you know them. Some perform comedy, act on stage or in film, or they are gifted musicians....

Sound the Alarm: Kirkland and Cooley Advise on Thoma Bravo’s plan to take Everbridge Private

Everbridge, Inc., a leader in national public warning solutions, announced it will be taken private via an acquisition by software investment firm Thoma Bravo....

Hedge Funds Watching Drug Makers

FOIAengine Breaks Down the Action  Financial firms are continuing to monitor many of the pharmaceutical manufacturers we’ve reported on in recent months, including Krystal Biotech,...